Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2018
Immune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapyG T King, P Sharma, S L Davis, et al.
Neuroendocrinology|January 1, 1978
Thyrotropin and prolactin secretory patterns during 24-hours infusion of thyrotropin-releasing hormone in calvesD L Ohlson, S L Davis, M S Anfinson, et al.
Endocrinology|April 1, 1985
Partial purification and characterization of somatomedin from sheep serumK L Hossner, S L Davis, C Powell, et al.
Biology of Reproduction|September 1, 1985
Ontogeny of growth hormone, prolactin, luteinizing hormone, and testosterone secretory patterns in the ramJ Klindt, D L Ohlson, S L Davis, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 7, 2013
The development of regorafenib and its current and potential future role in cancer therapyS L Davis, S G Eckhardt, W A Messersmith, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 1999
Organophosphorus-induced neurotoxicity in the absence of neuropathy target esterase inhibition: the effects of triphenyl phosphine in the European ferretS L Davis, D Tanaka, R J Aulerich, et al.
The American Journal of Physiology|December 1, 1977
Episodic growth hormone secretory patterns in sheep: relationship to gonadal steroid hormonesS L Davis, D L Ohlson, J Klindt, et al.
Pageof 15